Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01858 CHUNLI MEDICAL
RT Nominal down8.780 -0.190 (-2.118%)
Latest  |  Final  |  Interim
Non-current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others467,7861.019%463,069463,396392,949162,791
Land & other Lease Assets114,748-3.148%118,477120,967123,571102,348
Intangible Assets13,839-58.340%33,21919,07610,2011,204
Interests in Asso. & JCEs0--0000
Other Non-current Assets28,881-1.886%29,43627,23825,17223,509

625,254-2.941%644,201630,678551,893289,854
Current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories550,84326.780%434,486259,789159,677168,614
Trade Receivables378,711-14.265%441,721767,386527,789371,076
Cash & Bank Balances1,139,779-9.996%1,266,368957,1941,736,494690,116
Other Current Assets771,149-10.621%862,786794,72023,80422,187
Assets Held for Sale0--0000

2,840,481-5.486%3,005,3602,779,0892,447,7641,251,994
Current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables227,8451.040%225,500237,787142,41690,292
S-T Debt & Leases682-44.152%1,2216881,22611,456
Other Current Liabilities318,218-29.277%449,951357,330295,977267,098
Liab asso w/ Assets Held for Sale0--0000

546,745-19.201%676,673595,805439,619368,845
Net Current Assets2,293,736-1.501%2,328,6872,183,2842,008,145883,148
Total Assets Less Current Liabilities2,918,990-1.813%2,972,8882,813,9622,560,0381,173,002
Non-current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases184-65.325%5326260668
Other Non-current Liabilities97,4614.661%93,12193,63790,96192,746

97,6464.263%93,65394,26290,96193,414
Capital and Reserves
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital383,5690.000%383,569384,280384,280345,852
  Reserves2,436,334-2.308%2,493,8982,335,4202,084,797733,736
  Others0--0000
Shareholders' Funds2,819,902-2.001%2,877,4672,719,7002,469,0771,079,588
Non-controlling Interests1,442-18.474%1,769000
Others0--0000

2,821,344-2.011%2,879,2352,719,7002,469,0771,079,588
Commitments and Contingent Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments0--0000
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 16/04/2025 17:22
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 124,988,010
%Change-55.012%
EPS / (LPS)RMB 0.330
NBV Per Share (¥)RMB 7.368
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.